Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
60%(3 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_2
1
14%
Ph not_applicable
1
14%
Ph phase_3
1
14%
Ph phase_1
3
43%

Phase Distribution

3

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(5)
Terminated(2)

Detailed Status

Completed5
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (50.0%)
Phase 21 (16.7%)
Phase 31 (16.7%)
N/A1 (16.7%)

Trials by Status

terminated114%
completed571%
withdrawn114%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_1

Intraoperative Imaging of Pulmonary Nodules by OTL38

NCT02602119
withdrawnphase_1

OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer

NCT04941378
completedphase_2

Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer

NCT02317705
completedphase_3

OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

NCT03180307
completed

Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry

NCT02852252
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT02602119Phase 1

Intraoperative Imaging of Pulmonary Nodules by OTL38

Completed
NCT04941378Phase 1

OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer

Withdrawn
NCT02317705Phase 2

Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer

Completed
NCT03180307Phase 3

OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

Completed
NCT02852252

Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry

Completed
NCT02645409Not Applicable

Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma

Completed
NCT02629549Phase 1

Intraoperative Imaging of Pituitary Adenomas by OTL

Terminated

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7